Ann Walls Olmsted

Title: Ann Walls Olmsted: Innovator in Myocardial Imaging

Introduction

Ann Walls Olmsted is a prominent inventor based in Palo Alto, CA (US). She has made significant contributions to the field of myocardial imaging, holding 2 patents that focus on innovative methods for enhancing cardiac health.

Latest Patents

Her latest patents include groundbreaking methods for myocardial imaging accomplished by administering doses of a pharmaceutical composition comprising one or more adenosine A2A receptor agonists, particularly regadenoson. These methods are useful for myocardial imaging and coronary vasodilation, ensuring a minimal increase in average coronary peak flow velocity. Another notable patent involves the use of A2A adenosine receptor agonists to produce coronary vasodilation with minimal peripheral vasodilation, which is achieved by administering regadenoson in a sufficient amount to increase the average coronary peak flow velocity by at least about 16.5 cm/sec.

Career Highlights

Throughout her career, Ann has worked with notable companies such as Gilead Palo Alto, Inc. and Gilead Sciences, Inc. Her work has significantly impacted the pharmaceutical industry, particularly in the development of cardiac imaging techniques.

Collaborations

Ann has collaborated with esteemed colleagues, including Toufigh Gordi and Luiz Belardinelli, contributing to the advancement of her research and innovations.

Conclusion

Ann Walls Olmsted is a trailblazer in the field of myocardial imaging, with her patents paving the way for improved cardiac health solutions. Her contributions continue to influence the medical community and enhance patient care.